Publications
iScienceFeb 2024 |
27
(
2
),
108976
DOI:
10.1016/j.isci.2024.108976

Epitopes recognition of SARS-CoV-2 nucleocapsid RNA binding domain by human monoclonal antibodies

Kim, Youngchang; Maltseva, Natalia; Tesar, Christine; Jedrzejczak, Robert; Endres, Michael; Ma, Heng; Dugan, Haley L.; Stamper, Christopher T.; Chang, Changsoo; Li, Lei; Changrob, Siriruk; Zheng, Nai-Ying; Huang, Min; Ramanathan, Arvind; Wilson, Patrick; Michalska, Karolina; Joachimiak, Andrzej
Product Used
Genes
Abstract
Coronavirus nucleocapsid protein (NP) of SARS-CoV-2 plays a central role in many functions important for virus proliferation including packaging and protecting genomic RNA. The protein shares sequence, structure, and architecture with nucleocapsid proteins from betacoronaviruses. The N-terminal domain (NPRBD) binds RNA and the C-terminal domain is responsible for dimerization. After infection, NP is highly expressed and triggers robust host immune response. The anti-NP antibodies are not protective and not neutralizing but can effectively detect viral proliferation soon after infection. Two structures of SARSCoV-2 NPRBD were determined providing a continuous model from residue 48 to 173, including RNA binding region and key epitopes. Five structures of NPRBD complexes with human mAbs were isolated using an antigen-bait sorting. Complexes revealed a distinct complement-determining regions and unique sets of epitope recognition. This may assist in the early detection of pathogens and designing peptide-based vaccines. Mutations that significantly increase viral load were mapped on developed, full length NP model, likely impacting interactions with host proteins and viral RNA.
Product Used
Genes

Related Publications